Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel metabolic safety study in healthy women
2004-001614-13Phase 2Completed
- Sponsor
- Schering AG
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in contraception comparing Estradiol valerate + dienogest with Ethinylestradiol + levonorgestrel (2 arms). Primary endpoints: Lipid profile, Hemostatic variables and 1 more. Started Dec 2004; status: completed.
02
Drugs
estradiol valeratedienogestethinyl estradiolavatrombopag
03
Conditions
contraception
Beyond the preview
Go deeper on 2004-001614-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001614-13.